| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7648b65acedde648a74468f9aaafdda5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-302 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2001-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f88f83b275921fe70f48e4f7eb8d501 |
| publicationDate |
2002-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0210753-A2 |
| titleOfInvention |
Autoimmunity to angiotensin at1 receptors in schizophrenia |
| abstract |
A method of determining whether an individual has schizophrenia or the propensity to develop schizophrenia is provided. The method involves the detection of autoantibodies to the angiotensin AT1 receptor. Diagnostic kits and assays are also provided within the scope of the invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10132817-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9664687-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103154736-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2569630-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1884775-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8425877-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103154736-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2569630-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11435361-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8110374-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008015218-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8592164-B2 |
| priorityDate |
2000-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |